Clinical Trial Update: Empagliflozin in Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating empagliflozin for idiopathic pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Arterial Hypertension

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Idiopathic Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED